These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34507271)

  • 1. GABA
    Hu B; Geng C; Guo F; Liu Y; Zong YC; Hou XY
    Neurobiol Aging; 2021 Dec; 108():47-57. PubMed ID: 34507271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oligomeric amyloid-β peptide disrupts olfactory information output by impairment of local inhibitory circuits in rat olfactory bulb.
    Hu B; Geng C; Hou XY
    Neurobiol Aging; 2017 Mar; 51():113-121. PubMed ID: 28061384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An early dysregulation of FAK and MEK/ERK signaling pathways precedes the β-amyloid deposition in the olfactory bulb of APP/PS1 mouse model of Alzheimer's disease.
    Lachén-Montes M; González-Morales A; de Morentin XM; Pérez-Valderrama E; Ausín K; Zelaya MV; Serna A; Aso E; Ferrer I; Fernández-Irigoyen J; Santamaría E
    J Proteomics; 2016 Oct; 148():149-58. PubMed ID: 27498392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing GABAergic signaling ameliorates aberrant gamma oscillations of olfactory bulb in AD mouse models.
    Chen M; Chen Y; Huo Q; Wang L; Tan S; Misrani A; Jiang J; Chen J; Chen S; Zhang J; Tabassum S; Wang J; Chen X; Long C; Yang L
    Mol Neurodegener; 2021 Mar; 16(1):14. PubMed ID: 33663578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproic acid ameliorates olfactory dysfunction in APP/PS1 transgenic mice of Alzheimer's disease: Ameliorations from the olfactory epithelium to the olfactory bulb.
    Yao ZG; Jing HY; Wang DM; Lv BB; Li JM; Liu FF; Fan H; Sun XC; Qin YJ; Zhao MQ
    Pharmacol Biochem Behav; 2016 May; 144():53-9. PubMed ID: 26948859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interneurons and beta-amyloid in the olfactory bulb, anterior olfactory nucleus and olfactory tubercle in APPxPS1 transgenic mice model of Alzheimer's disease.
    Saiz-Sanchez D; De La Rosa-Prieto C; Ubeda-Bañon I; Martinez-Marcos A
    Anat Rec (Hoboken); 2013 Sep; 296(9):1413-23. PubMed ID: 23904197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olfactory dysfunction in the APP/PS1 transgenic mouse model of Alzheimer's disease: Morphological evaluations from the nose to the brain.
    Yao ZG; Hua F; Zhang HZ; Li YY; Qin YJ
    Neuropathology; 2017 Dec; 37(6):485-494. PubMed ID: 28643854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olfactory deficit is associated with mitral cell dysfunction in the olfactory bulb of P301S tau transgenic mice.
    Li S; Li W; Wu X; Li J; Yang J; Tu C; Ye X; Ling S
    Brain Res Bull; 2019 May; 148():34-45. PubMed ID: 30902575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Denervation of the olfactory bulb leads to decreased Aβ plaque load in a transgenic mouse model of Alzheimer' s disease.
    Bibari O; Lee S; Dickson TC; Mitew S; Vickers JC; Chuah MI
    Curr Alzheimer Res; 2013 Sep; 10(7):688-96. PubMed ID: 23905998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in Piriform and Bulbar Activity/Excitability/Coupling Upon Amyloid-β Administration in vivo Related to Olfactory Dysfunction.
    Martínez-García I; Hernández-Soto R; Villasana-Salazar B; Ordaz B; Peña-Ortega F
    J Alzheimers Dis; 2021; 82(s1):S19-S35. PubMed ID: 33459655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Locus coeruleus degeneration exacerbates olfactory deficits in APP/PS1 transgenic mice.
    Rey NL; Jardanhazi-Kurutz D; Terwel D; Kummer MP; Jourdan F; Didier A; Heneka MT
    Neurobiol Aging; 2012 Feb; 33(2):426.e1-11. PubMed ID: 21109328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid-β deposition and olfactory dysfunction in an Alzheimer's disease model.
    Wu N; Rao X; Gao Y; Wang J; Xu F
    J Alzheimers Dis; 2013; 37(4):699-712. PubMed ID: 23948910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ErbB4 deficiency exacerbates olfactory dysfunction in an early-stage Alzheimer's disease mouse model.
    Deng XH; Liu XY; Wei YH; Wang K; Zhu JR; Zhong JJ; Zheng JY; Guo R; Zhu YF; Ye QH; Wang MD; Chen YJ; He JQ; Chen ZX; Huang SQ; Lv CS; Zheng GQ; Liu SF; Wen L
    Acta Pharmacol Sin; 2024 Jul; ():. PubMed ID: 38982150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of GABA(A) receptors on GABAergic interneurons leads to increased oscillatory power in the olfactory bulb network.
    Nusser Z; Kay LM; Laurent G; Homanics GE; Mody I
    J Neurophysiol; 2001 Dec; 86(6):2823-33. PubMed ID: 11731539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA polymerase β decrement triggers death of olfactory bulb cells and impairs olfaction in a mouse model of Alzheimer's disease.
    Misiak M; Vergara Greeno R; Baptiste BA; Sykora P; Liu D; Cordonnier S; Fang EF; Croteau DL; Mattson MP; Bohr VA
    Aging Cell; 2017 Feb; 16(1):162-172. PubMed ID: 27686631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic anti-murine Aβ immunization preserves odor guided behaviors in an Alzheimer's β-amyloidosis model.
    Wesson DW; Morales-Corraliza J; Mazzella MJ; Wilson DA; Mathews PM
    Behav Brain Res; 2013 Jan; 237():96-102. PubMed ID: 23000537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impairment of Dendrodendritic Inhibition in the Olfactory Bulb of APP/PS1 Mice.
    Li W; Li S; Shen L; Wang J; Wu X; Li J; Tu C; Ye X; Ling S
    Front Aging Neurosci; 2019; 11():2. PubMed ID: 30740049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritoneal dialysis reduces amyloid-beta plasma levels in humans and attenuates Alzheimer-associated phenotypes in an APP/PS1 mouse model.
    Jin WS; Shen LL; Bu XL; Zhang WW; Chen SH; Huang ZL; Xiong JX; Gao CY; Dong Z; He YN; Hu ZA; Zhou HD; Song W; Zhou XF; Wang YZ; Wang YJ
    Acta Neuropathol; 2017 Aug; 134(2):207-220. PubMed ID: 28477083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GABAB Receptors Tune Cortical Feedback to the Olfactory Bulb.
    Mazo C; Lepousez G; Nissant A; Valley MT; Lledo PM
    J Neurosci; 2016 Aug; 36(32):8289-304. PubMed ID: 27511004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble β-amyloid impaired the GABA inhibition by mediating KCC2 in early APP/PS1 mice.
    Zhou Y; Cheng Y; Li Y; Ma J; Wu Z; Chen Y; Mei J; Chen M
    Biosci Trends; 2021 Nov; 15(5):330-340. PubMed ID: 34526443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.